跳至主要内容
临床试验/NCT03223246
NCT03223246已完成不适用

Medication Education for Dosing Safety

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2017年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
149
试验地点
2
主要终点
Number of Participants Reporting Safe Dosing at 48-72 Hours

研究概览

简要总结

Acetaminophen and ibuprofen are two of the most commonly used medication products among children <12 years old, and these medications are frequently prescribed for patients leaving the emergency department (ED), but previous studies have shown that parents often leave the ED unsure of how to safely dose these medications at home. This study will be a randomized controlled trial of a brief medication safety intervention, and examining parental knowledge and implementation of appropriate weight-based dosing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • parents of children between ages of 90 days to 11.9 years
  • being discharged with a plan for use of liquid acetaminophen (any age) or ibuprofen (limited to those >6 months old). The clinical team will determine planned medication use.
  • parental fluency in English or Spanish
  • ability to be reached by telephone over the next 7 days
  • planned discharge home.

排除标准

  • presence of a complex chronic condition in the child
  • planned use of a non-standard weight-based medication dose.
  • Families will also be excluded if the adult with the child is not a parent or legal guardian.

结局指标

主要结局

Number of Participants Reporting Safe Dosing at 48-72 Hours

时间窗: 48-72 hours

Number of participants reporting dosing within 20% of the weight-based dose for the child at 48-72 hours

次要结局

  • Number of Participants Reporting Contact With Other Providers at 48-72 Hours(48-72 hours)
  • Number of Participants Reporting Persistence of Safe Dosing at 5-7 Days(5-7 days)
  • Number of Participants Reporting Contact With Other Providers at 5-7 Days(5-7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Margaret Samuels-Kalow

Assistant Professor

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验